Gabriela Gruia
Net worth: 836 $ as of 2026-08-30
Net worth: 836 $ as of 2026-08-30
Gabriela Gruia is the founder of Dr. Gruia Consulting LLC, founded in 2021, serving as Principal since its founding.
Current jobs include Director at NETRIS Pharma SAS since 2023, Independent Director at TScan Therapeutics, Inc. since 2021, and Independent Director at Aprea Therapeutics, Inc. since 2023.
Former jobs include Independent Director at Tessa Therapeutics Ltd, Independent Director at Molecular Templates, Inc. from 2023 to 2024, SVP & Head-Global Regulatory Affairs at Novartis Oncology, Inc. from 2008 to 2020, and Chief Development Officer at Ichnos Glenmark Innovation, Inc. from 2020 to 2021.
Education includes a doctorate from Medicine & Pharmacy Carol Davila University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-15 | 1,045 ( 0.01% ) | 836 $ | 2026-08-30 | |
| 2026-05-19 | 0 ( -.--% ) | - $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 2021-05-26 |
| APREA THERAPEUTICS, INC. | Director/Board Member | 2023-05-04 |
Gabriela Gruia Consulting LLC | Founder | 2020-12-31 |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Director/Board Member | 2022-12-31 |
| Companies | Position | End |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Chief Tech/Sci/R&D Officer | 2023-10-01 |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Corporate Officer/Principal | 2020-12-31 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 2020-01-31 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Medicine & Pharmacy Carol Davila University of
Medicine & Pharmacy Carol Davila University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Gabriela Gruia Consulting LLC |
Select your edition
All financial news and data tailored to specific country editions